These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 31572167

  • 1. Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer's Disease.
    Hatashita S, Wakebe D, Kikuchi Y, Ichijo A.
    Front Aging Neurosci; 2019; 11():251. PubMed ID: 31572167
    [Abstract] [Full Text] [Related]

  • 2. [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease.
    Hatashita S, Yamasaki H, Suzuki Y, Tanaka K, Wakebe D, Hayakawa H.
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):290-300. PubMed ID: 24085503
    [Abstract] [Full Text] [Related]

  • 3. Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.
    Hatashita S, Wakebe D.
    J Alzheimers Dis; 2017 Feb; 57(3):765-773. PubMed ID: 28304292
    [Abstract] [Full Text] [Related]

  • 4. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM, Laymon CM, Cohen AD, Zhang Z, Price JC, Boudhar S, McDade E, Aizenstein HJ, Klunk WE, Mathis CA.
    Neuroimage Clin; 2015 Feb; 9():592-8. PubMed ID: 26640770
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
    Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL, Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group.
    Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
    [Abstract] [Full Text] [Related]

  • 10. Head-to-head comparison of 11C-PiB and 18F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients.
    Byun BH, Kim BI, Park SY, Ko IO, Lee KC, Kim KM, Kim YK, Lee JY, Bu SH, Kim JH, Chi DY, Ha JH, Lim SM.
    Medicine (Baltimore); 2017 Mar; 96(12):e6441. PubMed ID: 28328855
    [Abstract] [Full Text] [Related]

  • 11. Longitudinal assessment of amyloid-beta deposition in initially amyloid-negative non-demented individuals with [11C]-PIB PET imaging.
    Hatashita S, Wakebe D.
    Medicine (Baltimore); 2021 Sep 03; 100(35):e27055. PubMed ID: 34477136
    [Abstract] [Full Text] [Related]

  • 12. Amyloid β deposition and glucose metabolism on the long-term progression of preclinical Alzheimer's disease.
    Hatashita S, Wakebe D.
    Future Sci OA; 2019 Mar 03; 5(3):FSO356. PubMed ID: 30906564
    [Abstract] [Full Text] [Related]

  • 13. A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study.
    Villemagne VL, Rowe CC, Barnham KJ, Cherny R, Woodward M, Bozinosvski S, Salvado O, Bourgeat P, Perez K, Fowler C, Rembach A, Maruff P, Ritchie C, Tanzi R, Masters CL.
    Alzheimers Dement (N Y); 2017 Nov 03; 3(4):622-635. PubMed ID: 29201996
    [Abstract] [Full Text] [Related]

  • 14. Visual assessments of 11 C-Pittsburgh compound-B PET vs. 18 F-flutemetamol PET across the age spectrum.
    Zeydan B, Johnson DR, Schwarz CG, Przybelski SA, Lesnick TG, Senjem ML, Kantarci OH, Min PH, Kemp BJ, Jack CR, Kantarci K, Lowe VJ.
    Nucl Med Commun; 2024 Dec 01; 45(12):1047-1054. PubMed ID: 39267525
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET.
    Kim SE, Lee B, Park S, Cho SH, Kim SJ, Kim Y, Jang H, Jeong JH, Yoon SJ, Park KW, Kim EJ, Jung NY, Yoon B, Jang JW, Hong JY, Hwang J, Na DL, Seo SW, Choi SH, Kim HJ.
    Alzheimers Res Ther; 2020 Jan 04; 12(1):6. PubMed ID: 31901233
    [Abstract] [Full Text] [Related]

  • 20. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL, Ahlskog JE, Tosakulwong N, Senjem ML, Spychalla AJ, Petersen RC, Jack CR, Lowe VJ, Josephs KA.
    Parkinsonism Relat Disord; 2018 Mar 04; 48():3-9. PubMed ID: 29254665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.